Journal of General Internal Medicine

, Volume 25, Issue 8, pp 809–813 | Cite as

Impact of Diabetes on Postoperative Outcomes Following Colon Cancer Surgery

  • Nitasha Anand
  • Christopher A. Chong
  • Rachel Y. Chong
  • Geoffrey C. Nguyen
Original Research



Diabetes is the sixth most common cause of death in the US and causes significant postoperative mortality and morbidity.


To characterize the impact of diabetes among patients undergoing surgery for colorectal cancer.


This is is a retrospective cohort study.


Patients in the Nationwide Inpatient Sample (NIS) who had undergone colorectal cancer surgery between 1998 and 2005.


Using multivariate regression, we determined the association of diabetes status with postoperative mortality, postoperative complications, and length of stay.

Key Results

An estimated 218,534 patients had undergone surgery for colorectal cancer. We categorized subjects by the presence of diabetes, the prevalence of which was 15%. Crude postoperative in-hospital mortality was lower among diabetics compared to non-diabetics (2.5% vs. 3.2%, P < 0.0001). Adjusted mortality was 23% lower in those with diabetes compared to non-diabetics (aOR 0.77; 95% CI: 0.71–0.84). Diabetics also had lower adjusted post-operative complications compared to non-diabetics (aOR 0.82; 95% CI: 0.79–0.84). In uninsured individuals and patients <50 years of age, there was no protective association between diabetes and either in-hospital mortality or postoperative complications.


In patients undergoing colorectal cancer surgery, those with diabetes had a 23% lower mortality and fewer postoperative complications compared to non-diabetics. The mechanisms underlying this unexpected observation warrant further investigation.


diabetes nationwide colorectal cancer hyperglycemia 


  1. 1.
    National Estimates of Diabetes, Center for Disease Control and Prevention. National Diabetes fact sheet:general information and national estimates on diabetes in the United States, 2005. Available at:
  2. 2.
    Root HF. Preoperative medical care of the diabetic patient. Postgrad Med. 1966;40(4):439–44.PubMedGoogle Scholar
  3. 3.
    Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27(2):553–91.CrossRefPubMedGoogle Scholar
  4. 4.
    Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229–34.CrossRefPubMedGoogle Scholar
  5. 5.
    Coursin DB, Connery LE, Ketzler JT. Perioperative diabetic and hyperglycemic management issues. Crit Care Med. 2004;32(4 Suppl):S116–25.CrossRefPubMedGoogle Scholar
  6. 6.
    Gil-Bona J, Sabate A, Pi A, Adroer R, Jaurrieta E. Mortality risk factors in surgical patients in a tertiary hospital: a study of patient records in the period 2004-2006. Cir Esp. 2009;85(4):229–37.CrossRefPubMedGoogle Scholar
  7. 7.
    Lange CP, Ploeg AJ, Lardenoye JW, Breslau PJ. Patient-and procedure-specific risk factors for postoperative complications in peripheral vascular surgery. Qual Saf Health Care. 2009;18(2):131–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Chen SY, Zhou YB, Wang H, Li SK, Mao WZ, Wang HB. Risk factors of intra-abdominal infection following gastrectomy in gastric cancer patients. Zhonghua Wei Chang Wai Ke Za Zhi. 2009;12(2):137–40.PubMedGoogle Scholar
  9. 9.
    Malone DL, Genuit T, Tracy JK, Gannon C, Napolitano LM. Surgical site infections: reanalysis of risk factors. J Surg Res. 2002;103(1):89–95.CrossRefPubMedGoogle Scholar
  10. 10.
    Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341(25):1906–12.CrossRefPubMedGoogle Scholar
  11. 11.
    Mowat A, Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med. 1971;284(12):621–7.PubMedGoogle Scholar
  12. 12.
    Bagdade JD, Stewart M, Walters E. Impaired granulocyte adherence. A reversible defect in host defense in patients with poorly controlled diabetes. Diabetes. 1978;27(6):677–81.CrossRefPubMedGoogle Scholar
  13. 13.
    Kersten JR, Schmeling TJ, Orth KG, Pagel PS, Warltier DC. Acute hyperglycemia abolishes ischemic preconditioning in vivo. Am J Physiol. 1998;275(2 Pt 2):H721–5.PubMedGoogle Scholar
  14. 14.
    Whalen D, Houchens R, ELixhauser A. 2002 HCUP nationwide Inpatient Sample (NIS) comparison report #2005-03 ed. Rockville, MD:US. Agency for Healthcare Research and Quality 2005;1-89.Google Scholar
  15. 15.
    Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180(8):821–7.PubMedGoogle Scholar
  16. 16.
    Auerbach AD, Rasic MA, Sehgal N, Ide B, Stone B, Maselli J. Opportunity missed: medical consultation, resource use, and quality of care of patients undergoing major surgery. Arch Intern Med. 2007;167(21):2338–44.CrossRefPubMedGoogle Scholar
  17. 17.
    Jencks SF. Accuracy in recorded diagnoses. JAMA. 1992;267(16):2238–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Levetan CS, Passaro M, Jablonski K, Kass M, Ratner RE. Unrecognized diabetes among hospitalized patients. Diabetes Care. 1998;21(2):246–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978–82.CrossRefPubMedGoogle Scholar
  20. 20.
    van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359–67.CrossRefPubMedGoogle Scholar
  21. 21.
    Detsky AS, Abrams HB, Forbath N, Scott JG, Hilliard JR. Cardiac assessment for patients undergoing noncardiac surgery. A multifactorial clinical risk index. Arch Intern Med. 1986;146(11):2131–4.CrossRefPubMedGoogle Scholar
  22. 22.
    Detsky AS, Abrams HB, McLaughlin JR, Drucker DJ, Sasson Z, Johnston N, et al. Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med. 1986;1(4):211–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Goldman L, Caldera DL, Nussbaum SR, Southwick FS, Krogstad D, Murray B, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 1977;297(16):845–50.PubMedCrossRefGoogle Scholar
  24. 24.
    Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100(10):1043–9.PubMedGoogle Scholar
  25. 25.
    Kern EF, Maney M, Miller DR, Tseng CL, Tiwari A, et al. Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes. Healthy Serv Res. 2006;41(2):564–80.CrossRefGoogle Scholar
  26. 26.
    Newton KM, Wagner EH, Ramsey SD, McCulloch D, Evans R, et al. The use of automated data to identify complications and comorbidities of diabetes: a validation study. J Clin Epidemiol. 1999;52(3):199–207.CrossRefPubMedGoogle Scholar

Copyright information

© Society of General Internal Medicine 2010

Authors and Affiliations

  • Nitasha Anand
    • 1
  • Christopher A. Chong
    • 2
    • 3
  • Rachel Y. Chong
    • 3
  • Geoffrey C. Nguyen
    • 1
    • 4
  1. 1.Mount Sinai Hospital Division of GastroenterologyUniversity of Toronto Faculty of MedicineTorontoCanada
  2. 2.Queen’s University Faculty of Health SciencesKingstonCanada
  3. 3.Department of MedicineLakeridge HealthOshawaCanada
  4. 4.Johns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations